PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy

Background: The prognostic relevance of the PIK3CA mutation together with PD-L1, c-Met, and mismatch repair deficiency (dMMR) have not been fully investigated in Asian women with breast cancer (BC) who have undergone postoperative adjuvant chemotherapy. Methods: We analyzed PIK3CA mutations via pept...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Yoon Ah, Ko, Seung Yeon, Suh, Yong Joon, Kim, Sanghwa, Park, Jung Ho, Park, Hye-Rim, Seo, Jinwon, Choi, Hyo Geun, Kang, Ho Suk, Lim, Hyun, Park, Ha Young, Kwon, Mi Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140087/
https://www.ncbi.nlm.nih.gov/pubmed/35621626
http://dx.doi.org/10.3390/curroncol29050236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140087/
https://www.ncbi.nlm.nih.gov/pubmed/35621626
http://dx.doi.org/10.3390/curroncol29050236

Ejemplares similares